跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ESTELLE-35 TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
ESTELLE-35 TABLET
Approved
THERAPEUTIC
ESTELLE-35 TABLET
DOUGLAS PHARMACEUTICALS LTD
🇸🇬 Health Sciences Authority
Approval Date
Oct 31, 2002
Approval ID
c9674c1bbbc10736
Company
DOUGLAS PHARMACEUTICALS LTD
Type
Therapeutic
Approval Details
Approval Id
c9674c1bbbc10736
Drug Name
ESTELLE-35 TABLET
Product Name
ESTELLE-35 TABLET
Approval Number
SIN12117P
Approval Date
2002-10-31
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
G03HB01
Atc Item Name
cyproterone and estrogen
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Company Detail Path
/organization/apex-pharma-marketing-pte-ltd
Active Ingredients
ETHINYLOESTRADIOL
0.035 mg
CYPROTERONE ACETATE
2 mg
CYPROTERONE ACETATE
2 mg
ETHINYLOESTRADIOL
0.035 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 31, 2002
Approval ID
c9674c1bbbc10736
Type
Therapeutic
Back to HSA Approvals